---
figid: PMC9604797__marinedrugs-20-00618-g007
figtitle: Carotenoids from Marine Microalgae as Antimelanoma Agents
organisms:
- Saccharomyces cerevisiae
- PX clade
- Chlorophyta
- Phaeophyceae
- Haematococcus lacustris
- Porphyridium purpureum
- Tisochrysis lutea
- Eisenia bicyclis
- Cyanophora paradoxa
- Chlorophyta sp. IL5
- Rhodomonas salina
- Heterocapsa triquetra
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9604797
filename: marinedrugs-20-00618-g007.jpg
figlink: /pmc/articles/PMC9604797/figure/marinedrugs-20-00618-f007/
number: F7
caption: Aberrations in the MAPK (RAS-RAF-ERK) signaling pathway leading to chemoresistance.
  BRAFV600E is inhibited by BRAFi, causing inactivation of the MAPK pathway. Amplification
  or alternative splicing of BRAFV600E (BRAFmut) reactivates MAPK pathway in BRAFi-resistant
  tumors. In addition, the MAPK pathway can be reactivated by mutations affecting
  NF1, NRAS or MEK proteins in BRAFi-resistant tumors.
papertitle: Carotenoids from Marine Microalgae as Antimelanoma Agents.
reftext: Christiane Adrielly Alves Ferraz, et al. Mar Drugs. 2022 Oct;20(10):618.
year: '2022'
doi: 10.3390/md20100618
journal_title: Marine Drugs
journal_nlm_ta: Mar Drugs
publisher_name: MDPI
keywords: marine carotenoids | marine pigments | melanoma | pigments | skin cancer
automl_pathway: 0.938211
figid_alias: PMC9604797__F7
figtype: Figure
redirect_from: /figures/PMC9604797__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9604797__marinedrugs-20-00618-g007.html
  '@type': Dataset
  description: Aberrations in the MAPK (RAS-RAF-ERK) signaling pathway leading to
    chemoresistance. BRAFV600E is inhibited by BRAFi, causing inactivation of the
    MAPK pathway. Amplification or alternative splicing of BRAFV600E (BRAFmut) reactivates
    MAPK pathway in BRAFi-resistant tumors. In addition, the MAPK pathway can be reactivated
    by mutations affecting NF1, NRAS or MEK proteins in BRAFi-resistant tumors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nf1
  - Mdk
  - Ephb2
  - Mapk1
  - Ntrk1
  - Zhx2
  - Mmut
  - NF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - TKTL1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MMUT
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - dock
  - Doc3
  - Doc2
  - Doc1
  - Yif1
  - lov
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - cu
  - Raf
---
